Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series

Dermatology ◽  
2014 ◽  
Vol 228 (3) ◽  
pp. 211-214 ◽  
Author(s):  
Antonio Vitale ◽  
Donato Rigante ◽  
Francesco Caso ◽  
Maria Giuseppina Brizi ◽  
Mauro Galeazzi ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Interleukin 1 ◽  
Case Series ◽  
Behcet's Disease

scholarly journals Investigation of the role of interleukin-1 receptor antagonist VNTR variant on the Behçet’s disease

2018 ◽  
Vol 5 (1) ◽  
pp. 27-31
Author(s):  
Gul Dursun ◽  
Ayse Feyda Nursal ◽  
Helin Deniz Demir ◽  
Nevin Karakus ◽  
Osman Demir ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Interleukin 1 ◽  
Behcet's Disease ◽  
Interleukin 1 Receptor Antagonist

scholarly journals Pseudotumoural presentation of neuro-Behcet's disease: case series and review of literature

Rheumatology ◽  
2012 ◽  
Vol 51 (7) ◽  
pp. 1216-1225 ◽  
Author(s):  
N. Noel ◽  
M. Hutie ◽  
B. Wechsler ◽  
S. Vignes ◽  
D. Le Thi Huong-Boutin ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Case Series ◽  
Review Of Literature ◽  
Behcet's Disease ◽  
Disease Case

scholarly journals Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious Uveitis

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Daniel Sánchez-Cano ◽  
José Luis Callejas-Rubio ◽  
Ricardo Ruiz-Villaverde ◽  
Raquel Ríos-Fernández ◽  
Norberto Ortego-Centeno
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Case Reports ◽  
Certolizumab Pegol ◽  
Case Series ◽  
Behcet's Disease ◽  
Off Label ◽  
Inflammatory Bowel ◽  
Necrosis Factor

Tumoral necrosis factorαplays a central role in both the inflammatory response and that of the immune system. Thus, its blockade with the so-called anti-TNF agents (infliximab, etanercept, adalimumab, certolizumab pegol, and golimumab) has turned into the most important tool in the management of a variety of disorders, such as rheumatoid arthritis, spondyloarthropatties, inflammatory bowel disease, and psoriasis. Nonetheless, theoretically, some other autoimmune disorders may benefit from these agents. Our aim is to review these off-label uses of anti-TNF blockers in three common conditions: Behçet’s disease, sarcoidosis, and noninfectious uveitis. Due to the insufficient number of adequate clinical trials and consequently to their lower prevalence compared to other immune disorders, this review is mainly based on case reports and case series.

scholarly journals The dermatoscopy in the skin pathergy testing: case series in patients with suspected Behçet's Disease

2014 ◽  
Vol 54 (6) ◽  
pp. 494-498
Author(s):  
Maria Antonieta Rios Scherrer ◽  
Lúcia Porto Fonseca de Castro ◽  
Vanessa Barreto Rocha ◽  
Leonardo Pacheco
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Case Series ◽  
Behcet's Disease ◽  
Testing Case

scholarly journals 280. MANAGEMENT OF REFRACTORY VASCULAR BEHÇET’S DISEASE WITH TNF INHIBITORS: A RETROSPECTIVE MULTI-CENTER CASE SERIES

Rheumatology ◽  
2019 ◽  
Vol 58 (Supplement_2) ◽  
Author(s):  
Fatma Alibaz-Oner ◽  
Aysun Aksoy ◽  
Ayten Yazıcı ◽  
Ahmet Omma ◽  
Ayşe Çefle ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Case Series ◽  
Tnf Inhibitors ◽  
Behcet's Disease

Behcet’s disease and severe inflammatory reaction to 23-valent pneumococcal polysaccharide vaccine: a case report and review of literature

2018 ◽  
Vol 63 (4) ◽  
pp. 119-121 ◽  
Author(s):  
MohammadMahdi Saeidinejad ◽  
Sally Kardash ◽  
Laura Connell
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Case Series ◽  
Polysaccharide Vaccine ◽  
Inflammatory Rheumatic Diseases ◽  
Pneumococcal Polysaccharide Vaccine ◽  
Behcet's Disease ◽  
European League Against Rheumatism ◽  
Systemic Adverse Reaction

Current European League Against Rheumatism guidelines strongly recommend considering the use of polysaccharide pneumococcal vaccine in all patients with autoimmune inflammatory rheumatic diseases. However, a previously published case series reports of reactions to 23-valent pneumococcal polysaccharide vaccine in patients with Behcet’s disease. The purpose of this report is to present a similar case of a systemic adverse reaction in a patient with Behcet’s disease to 23-valent pneumococcal polysaccharide vaccine.

Specific interleukin-1 gene polymorphisms in Turkish patients with Behcet's disease

2005 ◽  
Vol 14 (2) ◽  
pp. 124-129 ◽  
Author(s):  
Mesut Coskun ◽  
Ali Bacanli ◽  
Nilgun Sallakci ◽  
Erkan Alpsoy ◽  
Ugur Yavuzer ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Gene Polymorphisms ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Interleukin 1 ◽  
Behcet's Disease ◽  
Turkish Patients

The Presentation of Headache in Neuro-Behçet's Disease: A Case-Series

2009 ◽  
Vol 49 (3) ◽  
pp. 467-470 ◽  
Author(s):  
Nilufer Kale ◽  
Jale Agaoglu ◽  
Murat Icen ◽  
Isil Yazici ◽  
Osman Tanik
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Case Series ◽  
Behcet's Disease

Pre-papillary vitreous opacities associated with Behçet’s disease: a case series and review of the literature

2017 ◽  
Vol 255 (10) ◽  
pp. 2017-2021 ◽  
Author(s):  
Lindsay A. Grotting ◽  
Samaneh Davoudi ◽  
Eduardo Uchiyama ◽  
Ann-Marie Lobo ◽  
George N. Papaliodis ◽  
...  
Keyword(s):  
Behçet’S Disease ◽  
Behcet’S Disease ◽  
Behçet's Disease ◽  
Case Series ◽  
Review Of The Literature ◽  
Behcet's Disease ◽  
Vitreous Opacities
Sign in / Sign up

Export Citation Format

Share Document